The human-relevant data TARA generates can empower both drug companies and medical professionals to make better decisions about treatments, on the level of individual patients and populations.

Predictive tissue models enable us to reduce cycle times in the development of life-saving drugs. Treatments for the greatest health challenges today can make it to market more quickly and with greater safety.